Publicaciones científicas

Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma

Krzeminski P (1), Sarasquete ME (2), Misiewicz-Krzeminska I (3), Corral R (2), Corchete LA (2), Martín AA (2), García-Sanz R (2), San Miguel JF (4), Gutiérrez NC (5).
(1) Servicio de Hematología, Hospital Universitario, IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.
(2) Servicio de Hematología, Hospital Universitario, IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.
(3) Servicio de Hematología, Hospital Universitario, IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain; National Health Institute, Warsaw, Poland.
(4) Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Pamplona, Navarra, Spain.
(5) Servicio de Hematología, Hospital Universitario, IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain

Revista: Biochimica et Byophysica Acta

Fecha: 11-dic-2014

Hematología y Hemoterapia

RESUMEN

MiR-155 plays a critical role in the development of B-cell malignancies. Previous studies have shown a deregulation of miR-155 in specific cytogenetic subtypes of multiple myeloma (MM).

In the present study, we explored the regulation of miRNA-155 in MM by DNA methylation mechanisms. qRT-PCR analysis revealed that miR-155 was differentially expressed in MM and its upregulation was associated with longer survival.

DNA methylation of CpG island present in the first exon of miR-155 host gene was associated with its low expression in MM cell lines and patient samples. Our results showed for the first time that in vitro methylation of part of the promoter and first exon abrogated the miR-155 expression.

We further showed that miR-155 expression in MM cell lines was increased by demethylating 5-aza-dC treatment and decreased by RNA-directed DNA methylation.

Additionally, we found that LPS "immunological challenge" was insufficient to induce miR-155 expression in MM cell lines with methylated DNA around transcription start site (TSS). This study provides evidence that DNA methylation contributes to miR-155 expression in myeloma cells.

CITA DEL ARTÍCULO  Biochim Biophys Acta. 2014 Dec 11. pii: S1874-9399(14)00296-X. doi: 10.1016/j.bbagrm.2014.12.002

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra